Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects - Wikidata - wikimedia - TriplyDB

Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects

Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects

http://www.wikidata.org/entity/Q30382813

about

Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A.Local inner ear application of dexamethasone in cochlear implant models is safe for auditory neurons and increases the neuroprotective effect of chronic electrical stimulation.

P2860

Q30383830-884BF3CB-D71C-4B29-A138-9B2D97234BD2 Q41577105-1876BC4F-CDD3-486F-9013-B80FD3B790C3

P2860

Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects

http://www.wikidata.org/entity/Q30382813

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Evaluation of the selective gl ...... ompound A for ototoxic effects

@ast

Evaluation of the selective gl ...... ompound A for ototoxic effects

@en

type

label

Evaluation of the selective gl ...... ompound A for ototoxic effects

@ast

Evaluation of the selective gl ...... ompound A for ototoxic effects

@en

prefLabel

Evaluation of the selective gl ...... ompound A for ototoxic effects

@ast

Evaluation of the selective gl ...... ompound A for ototoxic effects

@en

P1433

Q30382813-5CDFC15D-C7DD-41A7-AE0A-FAEC44D525DC

P1476

Q30382813-1C2EBD8C-2245-4D22-BFCA-AAA4C975825C

P2093

Q30382813-2426718F-376D-4E82-B84C-2A3D8848BEFD

Q30382813-6A4E6A51-3A41-4C08-94BA-715AEB46AA6E

Q30382813-6F0A6D5B-F5E3-45EA-B5D2-06D3117DC558

Q30382813-BEB83280-CE8B-4EDE-A282-0A990BDC753B

Q30382813-F813E42D-CAC8-45DB-A3AE-69E92645F373

Q30382813-FBE1A69C-2E23-45BD-A77A-39326507A9C8

Q30382813-FD6B3B16-0ADD-48B2-B462-0ABE5756F324

P2860

Q30382813-008B7780-269C-4867-98C6-405E6A1502E8

Q30382813-0F5D3690-F54C-451D-858B-F112CAF01E29

Q30382813-34CFBFD9-FF40-4A55-9296-9C16F6DEE4BB

Q30382813-3BFD052B-4CC5-4D1C-890F-EAB86C923D78

Q30382813-43C66C13-638F-4174-ABF4-D918E5B343AA

Q30382813-481F89E0-B0E3-48F8-9EC7-566568BD4BC2

Q30382813-4BA6D7AA-1F97-45E8-8022-424945E05347

Q30382813-65F9A88B-CFCD-4715-B2E4-0E6FB31F471D

Q30382813-716A678B-8030-4948-A3AB-C8F2592BAADD

Q30382813-74BCB7E3-1621-4EDC-8066-B9ACD40B82B6

P304

Q30382813-203E1E10-C4A6-4254-A64A-21742459AF9A

P31

Q30382813-448EF94D-B035-4BB4-A2AE-DB5A1C3E4EFA

P356

Q30382813-A6BB6FFC-413A-4D78-B4CD-1BAF325B60EC

P407

Q30382813-82DFB740-E882-4D8E-A0F5-E067B79AA2DF

P433

Q30382813-1F9CDEC2-5073-49F9-9470-AAE8A1461EBE

P478

Q30382813-09B00E42-0A7D-41F6-A572-9AC70FC376AE

P50

Q30382813-17C7BD44-A38B-47A0-95CD-F551FC4726DC

Q30382813-59EECC69-376D-481C-98C3-3C517CAD96B1

P577

Q30382813-9F28340F-343B-4FEC-972B-E00AD4781147

P5875

Q30382813-2608E03C-A937-462D-BFEF-693FDEB28224

P698

Q30382813-506D3C6A-BDEA-41B2-95CF-46861E526C49

P921

Q30382813-6D19E073-3B93-4528-AE4D-1AA78A76A030

Q30382813-CA27450D-3798-4715-95AC-E31CBBFD610E

P932

Q30382813-C3923DFC-3B4A-41C2-96E2-DD0581EBD093

P356

P1433

The Laryngoscope

P1476

Evaluation of the selective gl ...... ompound A for ototoxic effects

@en

P2093

Christoph Arnoldner

http://www.w3.org/2001/XMLSchema#string

Clemens Honeder

http://www.w3.org/2001/XMLSchema#string

Elisabeth Engleder

http://www.w3.org/2001/XMLSchema#string

Franz Gabor

http://www.w3.org/2001/XMLSchema#string

Hanna Schöpper

http://www.w3.org/2001/XMLSchema#string

Markus Krause

http://www.w3.org/2001/XMLSchema#string

Wolfgang Gstoettner

http://www.w3.org/2001/XMLSchema#string

P2860

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses.

Corticosteroid therapy for hearing and balance disorders

Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.

Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis.

A fully dissociated compound of plant origin for inflammatory gene repression

Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.

DNA binding of the glucocorticoid receptor is not essential for survival.

Steroids in otolaryngology.

Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

P304

E149-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LARY.25011

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Lukas D Landegger

Roberto Plasenzotti

P577

2014-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268080616

http://www.w3.org/2001/XMLSchema#string

P698

25382757

http://www.w3.org/2001/XMLSchema#string

P921

glucocorticoid receptor agonist

P932

4885662

http://www.w3.org/2001/XMLSchema#string